VEGFA and neutropenia: In this study, in addition to BEV, we used AFL or RAM as a VEGF inhibitor and patients treated with these types of VEGF inhibitors had experienced AEs, such as neutropenia, hypertension, and proteinuria more frequently than those treated with BEV.